Can the association of ciclosporine a and methotrexate maintain remission/low disease activity induced by etanercept in early rheumatoid arthritis patients? Evaluation by magnetic resonance imaging

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 301-305

  Picchianti Diamanti, A ^a   Argento, G ^a   Podesta E ^a   Germano, V ^a   Fazi, S ^a   Migliore, A ^b   David, V ^a   D'Amelio, R ^a   Lagana B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Early rheumatoid arthritis; Etanercept; High field magnetic resonance imaging; Remission

Indexed keywords

CYCLOSPORIN A; ETANERCEPT; METHOTREXATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EROSION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYNOVITIS; AGED; BONE EROSION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DISEASE ACTIVITY SCORE; DISEASE COURSE; DISEASE SEVERITY; EDEMA; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; TREATMENT OUTCOME;

EID: 84861462718     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500136     Document Type: Article

References (20)

1. Emery P, Kalden JR, Spencer-Green GT, Segrado OG. Adalimumab (HUMIRA) plus Methotrexate induces sustained remission in both early and long-standing rheumatoid arthritis. Arthritis Rheum 2004; 50:S183.
2. Wick MC, Lindblad S, Weiss RJ, et al. Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis. Ann Rheum Dis 2005; 64:134-7. (Pubitemid 40075291)
3. Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 2002; 46:1443-50. (Pubitemid 34620189)
4. Ostendorf B, Scherer A, Modder U, Schneider M. Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpophalangeal joints of the hands remain normal. Arthritis Rheum 2004; 50:2094-102. (Pubitemid 38924386)
5. Brown AK, Quinn MA, Karim Z, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006; 54:3761-73. (Pubitemid 44955876)
6. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48:1814-27. (Pubitemid 36828675)
7. Donahue KE, Gartlehner G, Jonas DE, et al. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 2008; 148:124-34. (Pubitemid 351651555)
8. Emery P, Breedveld FC, Hall S, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008; 372(9636):375-82.
9. Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological Disease-Modyfing Antirheumatic drugs. Annn Rheum Dis 2010; 69(6):964-75.
10. Laganà B, Picchianti Diamanti A, Ferlito C, et al. Imaging progression despite clinical remission in early rheumatoid arthritis patients after etanercept interruption. Int J Immunopathol Pharmacol 2009; 22(2):447-54.
11. Migliore A, Bizzi E, Massafra U, et al. A new chance to maintain remission induce by anti-tnf agents in rheumatoid arthritis patients: CynAR study II of a 12-month follow-up. Int J Immunopathol Pharmacol 2011; 24(1):167-74.
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism. Association 1987 Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24. (Pubitemid 18091653)
13. Conaghan P, Edmonds J, Emery P, et al. Magnetic resonance imaging in rheumatoid arthritis: summary of OMERACT activities, current status, and plans. J Rheumatol 2001; 28:1158-62.
14. Goekoop-Ruiterman YPM, Vries Bouwstra JK, Dijkmans BAC, et al. Clinical and radiographic outcome of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study). Arthritis Rheum 2005; 52:3381-90. (Pubitemid 41612204)
15. Breedveld FC, Kavanaugh AF, Cohen SB, et al. Early treatment of rheumatoid arthritis (RA) with adalimumab (HUMIRA) plus methotrexate vs adalimumab alone or methotrexate alone: the Premier study. Arthritis Rheum 2004; 50:4096.
16. Chen YF, Joban Putra P, Barton P, et al A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Tecnol Assess 2006; 10:1-229.
17. Greenberg JD, Reed G, Kremer JM, et al. Association of methotrexate and tumor necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis 2010; 69:380-6.
18. Nawata M, Saito K, Nakayamada S, Tanaka Y. Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission. Mod Rheumatol 2008; 18(5):460-4.
19. Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-TNF medication in early rheumatoid arthritis. Arthritis Rheum 2007; 57(8):1564-7. (Pubitemid 350308859)
20. Brown AK, Quinn MA, Emery P, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease modifying antirheumatic drug-induced clinical remission. Arthritis Rheum 2006; 54:3761-73. (Pubitemid 44955876)